Market open· · BRL · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
ALLOS S.A. (B3: ALOS3), the most innovative experience, entertainment, services, lifestyle and shopping platform in Latin America, announces its results for the second quarter of 2026 (2Q26). At the end of 2Q26, the Company held interests in 46 shopping centers, totaling 1,934 thousand sqm of Total GLA and 1,262 thousand sqm of Owned GLA. The Company also provided planning, administration and leasing services to 6 third-party shopping centers with a total GLA of 207.6 thousand sqm.
ALLOS (B3: ALOS3) announces its results for 1Q26. The Company held interests in 46 shopping centers, totaling 1,931 thousand sqm of Total GLA and 1,262 thousand sqm of Owned GLA. The Company also provided planning, administration and leasing services to 6 third-party shopping centers with a total GLA of 205.3 thousand sqm.
ALLOS S.A. announces its results for the fourth quarter of 2025 (4Q25). At the end of 4Q25, the Company held interest in 45 malls, totaling 1,938 thousand sqm of Total GLA and 1,265 thousand sqm of Owned GLA and provided planning, management and leasing services to 6 third-party malls with a total GLA of 190 thousand sqm.
Allos AI today announced $5 million in seed financing led by Oxford Science Enterprises (OSE) to commercialize the industry's first "glass-box" Causal AI platform, accelerating the end-to-end reformulation of complex generic drugs. The round also included participation from Habico Invest, the family office of Danish pharmaceutical group Orifarm, and the University of California accelerator Berkeley SKYDECK. The funding will support expansion across formulation development and data science as the
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.